EN DE
STOCK COMPARISON

Progyny vs UnitedHealth Group: Fair Value & Quality

Both stocks run through our valuation models. Here is how Progyny (PGNY) and UnitedHealth Group (UNH) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees UnitedHealth Group as the more attractively valued of the two: Progyny trades at $28.10 versus a fair value of $16.44 (-41%), while UnitedHealth Group trades at $407 versus $526 (+29%).
Progyny
PGNY · USD · Health Care
-41%
upside to fair value
overvalued
Price$28.10
Fair Value$16.44
Quality73/100
UnitedHealth Group
UNH · USD · Health Care
+29%
upside to fair value
undervalued
Price$407
Fair Value$526
Quality62/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

ProgynyUnitedHealth Group
Valuation
41.9×P/E (TTM)31.9×
1.93×P/S (TTM)0.86×
4.84×P/B4.09×
21.8×EV/EBITDA20.2×
—PEG1.49×
—Dividend yield2.1%
—Dividend per share$8.84
Profitability
5%Net margin3%
11%Operating margin8%
15%Return on equity12%
9%Return on assets4%
Growth
1%Revenue growth (YoY)2%
17.9%Avg. growth/yr (3Y)11.4%
30.2%Avg. growth/yr (5Y)11.7%
Balance & size
0.00×Debt / equity0.77×
$2BMarket cap$384B
healthyGrowth qualityhealthy

Progyny leads: 7 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Progynyof which business quality 74 · market factors 61 UnitedHealth Groupof which business quality 60 · market factors 82
ProfitabilityMargins and returns on capital today
61
52
Quality GrowthAre margins and returns improving?
45
48
CashflowEarnings quality: real cash, not paper profit
80
52
Fin. StrengthBalance sheet, leverage, solvency risk
90
51
InvestmentDisciplined investing over empire-building
63
76
Low VolatilityCalm price path (market factor)
36
69
MomentumPrice trend over the last 3–12 months (market factor)
77
87
52W MomentumDistance to the 52-week high (market factor)
64
88
Net IssuanceBuybacks instead of dilution
100
99

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Progyny

DCF Models$43.46
Earnings-Based$26.15
Multiples$16.00
Asset-Based$4.41
Growth DCF$52.81
Economic Profit$8.35
Growth Earnings$34.71

13 of 24 models see the stock below the current price.

UnitedHealth Group

DCF Models$362
Earnings-Based$196
Multiples$259
Asset-Based$69.43
Growth DCF$382
Economic Profit$186
Growth Earnings$292

19 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Progyny
Bear $12.33Fair Value $16.44Bull $20.54
$28.10 = current price (white tick)
UnitedHealth Group
Bear $368Fair Value $526Bull $657
$407 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Progyny · Health Care

Quality score73 · Top 25%
Fair value upside-41% · below median

UnitedHealth Group · Health Care

Quality score62 · above median
Fair value upside+29% · Top 25%

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees UnitedHealth Group as the more attractively valued of the two: Progyny trades at $28.10 versus a fair value of $16.44 (-41%), while UnitedHealth Group trades at $407 versus $526 (+29%).

Progyny has the higher quality score (73/100).

See the full analysis →
Progyny · UnitedHealth Group

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Progyny

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to UnitedHealth Group

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.